Acrigen Biosciences

Berkeley, United States

Acrigen Biosciences is dedicated to making gene editing safe.

Feb 2022

Grant

Top Investors

National Science FoundationAlexandria Venture InvestmentsRed Tree Venture CapitalBerkeley Catalyst Fund (BCF)Dolby Family Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acrigen Biosciences

Who are Acrigen Biosciences's investors?

Acrigen Biosciences's investors include National Science Foundation, Alexandria Venture Investments, Red Tree Venture Capital, Berkeley Catalyst Fund (BCF), Dolby Family Ventures.

Where is Acrigen Biosciences headquartered?

Acrigen Biosciences is headquartered in Berkeley, United States.

What does Acrigen Biosciences do?

Acrigen Biosciences is dedicated to making gene editing safe.

What stage is Acrigen Biosciences at?

Acrigen Biosciences is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 24, 2022.

MLA

"Acrigen Biosciences — Funding & Investors." VCBacked, February 24, 2022, https://www.vcbacked.co/company/acrigen-biosciences. Accessed July 1, 2026.

APA

VCBacked. (2022). Acrigen Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/acrigen-biosciences

Wikipedia (cite web)

{{cite web |title=Acrigen Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/acrigen-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 24, 2022.